Axim Biotechnologies Inc (OTCQB:AXIM)
| 0.6049 Delayed Data As of Sep 27 |  +0.0049 / +0.82%Today’s Change | 0.39 Today|||52-Week Range 1.22 | +39.76% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 134.2K | 713.3K | 2.1M | 1.8M | |
| Short Term Investment Cash | -527.0K | 579.2K | 1.4M | -252.2K | ||
| Cash & Short Term Investments | 134.2K | 713.3K | 2.1M | 2.0M | ||
| Receivables | Receivables | 5.0K | 505.0K | 5.0K | 5.0K | |
| Inventories | Inventories | 200.8K | 38.4K | 8.8K | 9.8K | |
| Current Assets | Prepaid Expenses | 777.7K | 40.8K | 41.0K | 52.1K | |
| Other Current Assets | 65.2K | 76.2K | 0.00 | 0.00 | ||
| Current Assets | 1.2M | 1.4M | 2.1M | 2.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 16.8K | 16.8K | 16.8K | 16.8K | |
| Depreciation | -1.1K | -4.5K | -7.8K | -11.2K | ||
| Intangible Assets | 63.2K | 63.2K | 63.2K | 53.7K | ||
| Other Assets | 63.2K | 63.2K | 70.6K | 61.1K | ||
| Total Assets | 1.3M | 1.4M | 2.2M | 2.1M | ||
| Liabilities | Accounts Payable | 335.2K | 401.2K | 441.8K | 217.7K | |
| Short Term Debt | 1.1M | 903.0K | 5.4M | 2.5M | ||
| Other Current Liabilities | 1.1M | 1.7M | 1.8M | 597.3K | ||
| Other Liabilities | 2.6M | 3.0M | 7.7M | 3.3M | ||
| Total Liabilities | Long Term Debt | 400.0K | 787.5K | 687.5K | 4.7M | |
| Other Liabilities | 0.00 | 16.4K | 84.0K | 132.7K | ||
| Total Liabilities | 3.0M | 3.8M | 8.5M | 8.2M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 200.00 | 100.00 | 100.00 | 100.00 | ||
| Common Equity | -1.7M | -2.4M | -6.3M | -6.1M | ||
| Total Shareholder Equity | -1.7M | -2.4M | -6.3M | -6.1M | ||
| Share Information | Common Shares Outstanding | 39.6M | 52.5M | 54.6M | 59.6M | |
| Addtl. Info. | No data currently available for this section. | |||||
